nach oben

Virchows Archiv

Erschienen in:

01.05.2009 | Original Article

Semaphorin3A immunohistochemical expression in human meningiomas: correlation with the microvessel density

verfasst von: Valeria Barresi, Enrica Vitarelli, Serenella Cerasoli

Erschienen in: Virchows Archiv | Ausgabe 5/2009

Einloggen, um Zugang zu erhalten

Abstract

The immunoexpression of the antiangiogenic factor semaphorin3A (SEMA3A) was evaluated in a series of meningiomas. Then, its correlations with the microvessel density (MVD) of the tumors and with the clinicopathological parameters as well with the survival time or recurrence-free interval were investigated. A positive SEMA3A immunostaining was found in most of meningiomas and a significant association was found between a high expression of this protein and a low MVD of the tumors. Moreover, a low SEMA3A immunoexpression was significantly correlated with a higher recurrence rate of meningiomas. In conclusion, our findings suggest a role for SEMA3A as an antiangiogenic factor in meningiomas with its decrease being associated with the development of recurrences. The supplementation of SEMA3A might be used in novel therapeutic antiangiogenic strategies to prevent the recurrence of highly vascularized meningiomas.

Perry A, Louis DN, Scheithauer BW et al (2007) Meningiomas. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO classification of tumors of the central nervous system. IARCC Press, Lyon, pp 164–172

Perry A, Stafford SL, Scheithauer BW et al (1999) “Malignancy” in meningiomas: a clinico-pathological study of 116 patients with grading implications. Cancer 85:2046–2056PubMed

Barresi V, Cerasoli S, Vitarelli E et al (2007) Density of microvessel positive for CD105 (endoglin) is related to prognosis in meningiomas. Acta Neuropathol 114:147–156PubMedCrossRef

Folkman J, Shing Y (1992) Angiogenesis. J Biol Chem 267:10931–10934PubMed

Luo Y, Raible D, Raper JA (1993) Collapsin: a protein in brain that induces the collapse and paralysis of neuronal growth cones. Cell 75:217–227PubMedCrossRef

Guttmann-Raviv N, Shraga-Heled N, Varshavsky A et al (2007) Semaphorin-3A and semaphoring-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis. J Biol Chem 282:26294–26305PubMedCrossRef

Soker S, Takashima S, Miao HQ et al (1998) Neuropilin-1 is expressed by endothelial and tumor cells as an isoform specific receptor for vascular endothelial growth factor. Cell 92:735–745PubMedCrossRef

Soker S, Maio HQ, Nomi M et al (2002) VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165 receptor binding. J Biol Chem 85:357–368

Miao HQ, Soker S, Feiner L et al (1999) Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165. J Cell Biol 12:233–242

10.

Narazaki M, Tosato G (2006) Ligand-induced internalization selects use of common receptor neuropilin-1 by VEGF165 and semaphorin3A. Blood 107:3892–3901PubMedCrossRef

11.

Simpson D (1957) The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20:22–39PubMedCrossRef

12.

Barresi V, Grosso M, Vitarelli E et al (2008) Endoglin (CD105) immuno-expression in human foetal and neonatal lungs. Histol Histopathol 23:701–708PubMed

13.

Barresi V, Cerasoli S, Tuccari G (2008) Correlative evidence that tumor cell-derived caveolin-1 mediates angiogenesis in meningiomas. Neuropathology 28:472–478PubMedCrossRef

14.

Barresi V, Vitarelli E, Tuccari G et al (2008) Correlative study of microvessel density and 5-lipoxygenase expression in human sporadic colorectal cancer. Arch Pathol Lab Med 132:1807–1812PubMed

15.

Villegas G, Tufro A (2002) Ontogeny of semaphorins 3A and 3F and their receptors neuropilins 1 and 2 in the kidney. Gene Expr Patterns 2:151–155PubMedCrossRef

16.

Gougos A, St Jacques S, Greaves A et al (1992) Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts. Int Immunol 4:83–92PubMedCrossRef

17.

Perry A, Stafford SL, Scheithauer BW et al (1998) The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas. Cancer 82:2262–2269PubMedCrossRef

18.

Ding S, Li C, Lin S et al (2006) Comparative evaluation of micorvessel density determined by CD34 or CD105 in benign and malignant gastric lesions. Hum Pathol 37:861–866PubMedCrossRef

19.

Saad RS, El-Gohary Y, Memari E et al (2005) Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in esophageal adenocarcinoma. Hum Pathol 36:955–961PubMedCrossRef

20.

Folkman J (1995) Clinical applications of angiogenic research. N Eng J Med 333:1757–1763CrossRef

21.

Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353–364PubMedCrossRef

22.

Pistolesi S, Boldrini L, Gisfredi S et al (2004) Angiogenesis in intracranial meningiomas: immunohistochemical and molecular study. Neuropathol Appl Neurobiol 30:118–25PubMedCrossRef

23.

Provias J, Claffey K, delAguila L et al (1997) Meningiomas: role of vascular endothelial growth factor/vascular permeability factor in angiogenesis and peritumoral edema. Neurosurgery 40:1016–1026PubMedCrossRef

24.

Rieger J, Wick W, Weller M (2003) Human malignant glioma cells express semaphorins and their receptors, neuropilins and plexins. Glia 42:379–389PubMedCrossRef

25.

Catalano A, Caprari P, Rodilossi S et al (2004) Crosstalk between vascular endothelial growth factor and semaphorin-3A pathway in the regulation of normal and malignant mesothelial cell proliferation. FASEB J 18:358–360PubMed

26.

Catalano A, Caprari P, Moretti S et al (2006) Semaphorin-3A is expressed by tumour cells and alters T-cell signal transduction and function. Blood 107:3321–3329PubMedCrossRef

27.

Müller MW, Giese NA, Swiercz JM et al (2007) Association of axon guidance factor Semaphorin 3A with poor outcome in pancreatic cancer. Int J Cancer 121:2421–2433PubMedCrossRef

28.

Osada R, Horiuchi A, Kikuchi N et al (2006) Expression of semaphorins, vascular endothelial growth factor and their common receptor neuropilins and allelic loss of semaphorin locus in epithaelial ovarian neoplasms: increased ratio of vascular endothelial growth factor to semaphoring is a poor prognostic factor in ovarian carcinomas. Hum Pathol 37:1414–1425PubMedCrossRef

29.

Miller DW, Graulich W, Karges B et al (1999) Elevated expression of endoglin, a component of the TGF-ß receptor complex, correlates with proliferation of tumour endothelial cells. Int J Cancer 81:568–572PubMedCrossRef

30.

Christov C, Lechapt-Zalcman E, Adle-Biassette H et al (1999) Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptor flt-1 in microcystic meningiomas. Acta Neuropathol 98:414–420PubMedCrossRef

31.

Kamitani H, Masuzawa H, Kanazawa I et al (2001) Recurrence of convexity meningiomas: tumour cells in the arachnoid membrane. Surg Neurol 56:228–235PubMedCrossRef

32.

Kinjo T, al-Mefty O, Kanaan I (1993) Grade zero removal of supratentorial convexity meningiomas. Neurosurgery 33:394–399PubMedCrossRef

Titel: Semaphorin3A immunohistochemical expression in human meningiomas: correlation with the microvessel density
verfasst von: Valeria Barresi
Enrica Vitarelli
Serenella Cerasoli
Publikationsdatum: 01.05.2009
Verlag: Springer-Verlag
Erschienen in: Virchows Archiv / Ausgabe 5/2009
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI: https://doi.org/10.1007/s00428-009-0757-3

Neu im Fachgebiet Pathologie

01.04.2024 | Forensische Traumatologie | CME

Springer Medizin

Semaphorin3A immunohistochemical expression in human meningiomas: correlation with the microvessel density

Abstract

Neu im Fachgebiet Pathologie

Theoretische Grundlagen von Explosionen und Explosionsverletzungen

Auswirkungen vorgeschalteter Laborprozesse auf die Digitalisierung histologischer Schnittpräparate

Knochenmarkhistologie bei Zytopenien

Herausforderungen der Automation bei der quantitativen Auswertung von Leberbiopsien

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2009

Diagnosis of autoimmune pancreatitis by core needle biopsy: application of six microscopic criteria

βIII-tubulin at the invasive margin of colorectal cancer: possible link to invasion

Association of hormone receptor status with grading, age of onset, and tumor size in BRCA1-associated breast cancer

Biliary intraductal papillary mucinous neoplasia: three case reports

Transcription factors Snail, Slug, Twist, and SIP1 in spindle cell carcinoma of the head and neck

Intraosseous lymphocytic infiltrates after hip resurfacing arthroplasty

Neu im Fachgebiet Pathologie

Theoretische Grundlagen von Explosionen und Explosionsverletzungen

Auswirkungen vorgeschalteter Laborprozesse auf die Digitalisierung histologischer Schnittpräparate

Knochenmarkhistologie bei Zytopenien

Herausforderungen der Automation bei der quantitativen Auswertung von Leberbiopsien